349 related articles for article (PubMed ID: 23117880)
21. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
22. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases.
Bernard ME; Wegner RE; Reineman K; Heron DE; Kirkwood J; Burton SA; Mintz AH
J Cancer Res Ther; 2012; 8(2):215-21. PubMed ID: 22842364
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors and impact of treatment in melanoma brain metastases: better prognosis for women?
Hofmann MA; Coll SH; Küchler I; Kiecker F; Wurm R; Sterry W; Trefzer U
Dermatology; 2007; 215(1):10-6. PubMed ID: 17587834
[TBL] [Abstract][Full Text] [Related]
24. Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases?
Franceschini D; Franzese C; Navarria P; Ascolese AM; De Rose F; Del Vecchio M; Santoro A; Scorsetti M
Cancer Treat Rev; 2016 Nov; 50():1-8. PubMed ID: 27566962
[TBL] [Abstract][Full Text] [Related]
25. [Current treatment of melanoma metastases of the brain].
Fedorcsák I; Sipos L
Magy Onkol; 2003; 47(1):109-12. PubMed ID: 12704463
[TBL] [Abstract][Full Text] [Related]
26. Advances in therapy for melanoma brain metastases.
Flanigan JC; Jilaveanu LB; Chiang VL; Kluger HM
Clin Dermatol; 2013; 31(3):264-81. PubMed ID: 23608446
[TBL] [Abstract][Full Text] [Related]
27. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
28. Treatment options for brain metastases from melanoma.
McWilliams RR; Rao RD; Brown PD; Link MJ; Buckner JC
Expert Rev Anticancer Ther; 2005 Oct; 5(5):809-20. PubMed ID: 16221051
[TBL] [Abstract][Full Text] [Related]
29. Miliary brain metastases from malignant melanoma.
Rainov NG; Burkert W
Zentralbl Neurochir; 1996; 57(1):20-4. PubMed ID: 8900895
[TBL] [Abstract][Full Text] [Related]
30. Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery.
Gaudy-Marqueste C; Dussouil AS; Carron R; Troin L; Malissen N; Loundou A; Monestier S; Mallet S; Richard MA; Régis JM; Grob JJ
Eur J Cancer; 2017 Oct; 84():44-54. PubMed ID: 28783540
[TBL] [Abstract][Full Text] [Related]
31. Can current prognostic scores reliably guide treatment decisions in patients with brain metastases from malignant melanoma?
Nieder C; Marienhagen K; Geinitz H; Grosu AL
J Cancer Res Ther; 2011; 7(1):47-51. PubMed ID: 21546742
[TBL] [Abstract][Full Text] [Related]
32. Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease.
Miranda EP; Gertner M; Wall J; Grace E; Kashani-Sabet M; Allen R; Leong SP
Arch Surg; 2004 Aug; 139(8):831-6; discussion 836-7. PubMed ID: 15302691
[TBL] [Abstract][Full Text] [Related]
33. Integration of gamma knife surgery in the management of cerebral metastases from melanoma.
Christopoulou A; Retsas S; Kingsley D; Paddick I; Lindquist C
Melanoma Res; 2006 Feb; 16(1):51-7. PubMed ID: 16432456
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer metastatic to the brain: time trends in presentation and outcome.
Nieder C; Pawinski A; Balteskard L
Oncology; 2009; 76(5):369-74. PubMed ID: 19321946
[TBL] [Abstract][Full Text] [Related]
35. Linear accelerator stereotactic radiosurgery for metastatic brain tumors: 17 years of experience at the University of Florida.
Swinson BM; Friedman WA
Neurosurgery; 2008 May; 62(5):1018-31; discussion 1031-2. PubMed ID: 18580799
[TBL] [Abstract][Full Text] [Related]
36. Utility of FDG PET/CT and brain MRI in melanoma patients with increased serum S-100B level during follow-up.
Aukema TS; Olmos RA; Korse CM; Kroon BB; Wouters MW; Vogel WV; Bonfrer JM; Nieweg OE
Ann Surg Oncol; 2010 Jun; 17(6):1657-61. PubMed ID: 20151211
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic radiosurgery for the treatment of brain metastases: impact of cerebral disease burden on survival.
Banfill KE; Bownes PJ; St Clair SE; Loughrey C; Hatfield P
Br J Neurosurg; 2012 Oct; 26(5):674-8. PubMed ID: 22747250
[TBL] [Abstract][Full Text] [Related]
38. The treatment of brain metastases in melanoma patients.
Bafaloukos D; Gogas H
Cancer Treat Rev; 2004 Oct; 30(6):515-20. PubMed ID: 15325032
[TBL] [Abstract][Full Text] [Related]
39. Long-term survivors after gamma knife radiosurgery for brain metastases.
Kondziolka D; Martin JJ; Flickinger JC; Friedland DM; Brufsky AM; Baar J; Agarwala S; Kirkwood JM; Lunsford LD
Cancer; 2005 Dec; 104(12):2784-91. PubMed ID: 16288488
[TBL] [Abstract][Full Text] [Related]
40. Factors affecting the outcome after treatment for metastatic melanoma to the brain.
Carrubba CJ; Vitaz TW
Surg Neurol; 2009 Dec; 72(6):707-11. PubMed ID: 19604550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
